Changing patterns of cancer incidence in the early-and late-HAART periods: The Swiss HIV Cohort Study

British Journal of Cancer

Volumn 103, Issue 3, 2010, Pages 416-422

  Franceschi, S ^a   Lise, M ^a,b   Clifford, G M ^a   Rickenbach, M ^c   Levi, F ^d,e   Maspoli, M ^e   Bouchardy, C ^f   Dehler, S ^g   Jundt, G ^h   Ess, S ⁱ   Bordoni, A ^j   Konzelmann, I ^k   Frick, H ^l   Dal Maso, L ^b   Elzi, L ^m   Furrer, H ⁿ   Calmy, A ^o   Cavassini, M ^d   Ledergerber, B ^p   Keiser, O ^q  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c Data Center   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Cancer Registry of the Canton of Neuchatel   (Switzerland)

^f GENEVA CANCER REGISTRY   (Switzerland)

^g Cancer Registry of the Canton of Zurich   (Switzerland)

^h Association of Swiss Cancer Registries   (Switzerland)

ⁱ Cancer Registry of St Gallen and Appenzell   (Switzerland)

^j Ticino Cancer Registry   (Switzerland)

^k Valais Cancer Registry   (Switzerland)

^l Cancer Registry of the Canton of Graubunden   (Switzerland)

^m UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^p UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^q UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

age; HAART; HIV; incidence rates; Switzerland

Indexed keywords

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN CANCER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHROMOSOME MAPPING; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; SARCOMA, KAPOSI; SKIN NEOPLASMS; SWITZERLAND;

EID: 77955057193     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605756     Document Type: Article

References (45)

1. Ancelle-Park R (1993) Expanded European AIDS case definition. Lancet 341: 441
2. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006) Hodgkin's lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108: 3786-3791
3. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10: 321-322
4. Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S, Gazzard B (2003) HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17: 371-375
5. Breslow NE, Day NE (1987) Statistical Methods in Cancer Research. Vol.II: The design and analysis of cohort studies. IARC Scientific Publications No.82 International Agency for Research on Cancer: Lyon
6. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA (2009) Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 101: 1120-1130
7. Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA (2007) Elevated risk of lung cancer among people with AIDS. AIDS 21: 207-213
8. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort Study (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425-432
9. Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, Rauch A, Probst-Hensch NM, Bouchardy C, Levi F, Franceschi S, Swiss HIV Cohort Study (2008) Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 22: 2135-2141
10. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents. Vol.IX. IARC Scientific Publication No.160 International Agency for Research on Cancer: Lyon
11. Dal Maso L, Braga C, Franceschi S (2001) Methodology used for 'software for automated linkage in Italy' (SALI). J Biomed Inform 34: 387-395
12. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, Tagliabue G, Zanetti R, Federico M, Limina RM, Mangone L, De Lisi V, Stracci F, Ferretti S, Piffer S, Budroni M, Donato A, Giacomin A, Bellù F, Fusco M, Madeddu A, Vitarelli S, Tessandori R, Tumino R, Suligoi B, Franceschi S; for the Cancer and AIDS Registries Linkage (CARL) Study (2009) Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 100: 840-847
13. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187-194
14. Franceschi S, Dal Maso L, Rickenbach M, Polesel J, Hirschel B, Cavassini M, Bordoni A, Elzi L, Ess S, Jundt G, Mueller N, Clifford GM, The Swiss HIV Cohort Study (2008) Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 99: 800-804
15. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International Classification of Diseases for Oncology. Third edition World Health Organization: Geneva
16. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D (2009) Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 10: 1152-1159
17. Hammer SM, Eron Jr JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA (2008) Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 300: 555-570
18. IARC (1994) Monographs on the Evaluation of Carcinogenic Risks to Humans Volume59: Hepatitis Viruses. International Agency for Research on Cancer: Lyon
19. IARC (1997) Monographs on the Evaluation of Carcinogenic Risks to Humans Volume70: Epstein-Barr Virus and Kaposi's Sarcoma Herpes-virus/Human Herpesvirus 8. International Agency for Research on Cancer: Lyon
20. IARC (2000) Monographs on the Evaluation of Carcinogenic Risks to Humans Volume76: Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents. International Agency for Research on Cancer: Lyon
21. IARC (2007) Monographs on the Evaluation of Carcinogenic Risks to Humans Volume90: Human Papillomaviruses. International Agency for Research on Cancer: Lyon
22. Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, Rickenbach M (2004) All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 18: 1835-1843
23. Kirk GD, Merlo C, O'Driscoll P, Mehta SH, Galai N, Vlahov D, Samet J, Engels EA (2007) HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 45: 103-110
24. Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni Jr JF, Engels EA (2009) Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS 23: 385-393
25. Ledergerber B, Telenti A, Egger M, for the Swiss HIV Cohort Study (1999) Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ 319: 23-24
26. Monini P, Sgadari C, Toschi E, Barillari G, Ensoli B (2004) Antitumour effects of antiretroviral therapy. Nat Rev Cancer 4: 861-875
27. Olivero OA (2007) Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen 48: 215-223
28. Parkin DM, Muir C, Whelan S, Gao YT, Ferley J, Powell J (1992) Cancer Incidence in Five Continents. Vol.VI. IARC Scientific Publications No.120 International Agency for Research on Cancer: Lyon
29. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer Incidence in Five Continents. Vol.VII. IARC Scientific Publications No.143 International Agency for Research on Cancer: Lyon
30. Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L (2002) Cancer Incidence in Five Continents. Volume VIII. IARC Scientific Publications No.155 International Agency for Research on Cancer: Lyon
31. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT (2008) Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 148: 728-736
32. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, Costagliola D, Mary-Krause M (2008) Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 22: 1203-1211
33. Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S, The Swiss HIV Cohort Study (2008) Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 22: 301-306
34. Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, Vercelli M, Zanetti R, Tagliabue G, Russo A, Luminari S, Stracci F, De Lisi V, Ferretti S, Mangone L, Budroni M, Limina RM, Piffer S, Serraino D, Bellù F, Giacomin A, Donato A, Madeddu A, Vitarelli S, Fusco M, Tessandori R, Tumino R, Piselli P, Dal Maso L; for the Cancer and AIDS Registries Linkage (CARL) Study (2010) Cancer incidence in people with AIDS in Italy. Int J Cancer; e-pub ahead of print 4 January 2010
35. Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Moller H, Bower M (2009) Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 27: 884-890
36. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, Precone D, Gelatti U, Asensi V, Vaccher E (2004) Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 18: 2285-2293
37. Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M, Michelet C, Pol S, Perronne C, Cacoub P (2007) Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat 14: 183-188
38. Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Third edn, pp 55-56. Lippincott Williams & Wilkins: Philadelphia
39. Schoenbach VJ (2000) Chapter 6: Standardization of rates and ratios. In: Understanding the Fundamentals of Epidemiology: An Evolving Text. Schoenbach VJ, Rosamund WD (eds) pp 129-151. University of North Carolina at Chapel Hill: Chapel Hill, (available from http://www. epidemiolog.net/evolving/ Standardization.pdf)
40. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group (2009) Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination anti-retroviral therapy: a European multicohort study. Antivir Ther 14: 1065-1074
41. The D:A:D Study Group (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166: 1632-1641
42. The Swiss HIV Cohort Study (2010) Cohort Profile: the Swiss HIV Cohort Study. Int J Epidemiol; e-pub ahead of print 30 November 2009
43. van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, Grulich AE (2009) Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretro-viral therapy. AIDS 23: 2183-2190
44. Vo TT, Ledergerber B, Keiser O, Hirschel B, Furrer H, Battegay M, Cavassini M, Bernasconi E, Vernazza P, Weber R (2008) Durability and outcome of initial antiretroviral treatments received during 2000-2005 by patients in the Swiss HIV Cohort Study. J Infect Dis 197: 1685-1694
45. World Health Organisation (1992) International Statistical Classification of Disease and Related Health Problems. 10th revision WHO: Geneva